Marlen Kolb

Head And Neck Surgery, Liebigstr. 10-14
Leipzig, SN 04103, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

High-Risk Human Papillomavirus (HR-HPV) DNA Detection in Mouthwashes for Diagnosis of HPV-Driven Oropharynx Cancer and Its Curative Therapy-A Feasibility Study.

High-Risk Human Papillomavirus (HR-HPV) DNA Detection in Mouthwashes for Diagnosis of HPV-Driven Oropharynx Cancer and Its Curative Therapy-A Feasibility Study.

Journal: Journal of clinical medicine
Published: July 15, 2022

Pre-Therapeutic VEGF Level in Plasma Is a Prognostic Bio-Marker in Head and Neck Squamous Cell Carcinoma (HNSCC).

Pre-Therapeutic VEGF Level in Plasma Is a Prognostic Bio-Marker in Head and Neck Squamous Cell Carcinoma (HNSCC).

Journal: Cancers
Published: June 04, 2021

Micronucleus Formation in Primary Oropharyngeal Epithelial Cells Reveals Mutagenicity of Cement Dusts.

Micronucleus Formation in Primary Oropharyngeal Epithelial Cells Reveals Mutagenicity of Cement Dusts.

Journal: Anticancer research
Published: December 23, 2020

Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.

Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.

Journal: Cancer
Published: August 09, 2019

Discrimination of Head and Neck Squamous Cell Carcinoma Patients and Healthy Adults by 10-Color Flow Cytometry: Development of a Score Based on Leukocyte Subsets.

Discrimination of Head and Neck Squamous Cell Carcinoma Patients and Healthy Adults by 10-Color Flow Cytometry: Development of a Score Based on Leukocyte Subsets.

Journal: Cancers
Published: March 22, 2019

Leptin decreases circulating inflammatory IL-6 and MCP-1 in mice.

Leptin decreases circulating inflammatory IL-6 and MCP-1 in mice.

Journal: BioFactors (Oxford, England)
Published: July 09, 2018

Correction: The anti-tumorigenic activity of A2M-A lesson from the naked mole-rat.

Correction: The anti-tumorigenic activity of A2M-A lesson from the naked mole-rat.

Journal: PloS one
Published: March 27, 2018

Development of a Human Leukocyte Antigen Score to Predict Progression-Free Survival in Head and Neck Squamous Cell Carcinoma Patients.

Development of a Human Leukocyte Antigen Score to Predict Progression-Free Survival in Head and Neck Squamous Cell Carcinoma Patients.

Journal: Frontiers in oncology
Published: March 07, 2018

The anti-tumorigenic activity of A2M-A lesson from the naked mole-rat.

The anti-tumorigenic activity of A2M-A lesson from the naked mole-rat.

Journal: PloS one
Published: September 25, 2017

Reduced Cytokine Release in Ex Vivo Response to Cilengitide and Cetuximab Is a Marker for Improved Survival of Head and Neck Cancer Patients.

Reduced Cytokine Release in Ex Vivo Response to Cilengitide and Cetuximab Is a Marker for Improved Survival of Head and Neck Cancer Patients.

Journal: Cancers
Published: June 30, 2017

Verification and characterization of an alternative low density lipoprotein receptor-related protein 1 splice variant.

Verification and characterization of an alternative low density lipoprotein receptor-related protein 1 splice variant.

Journal: PloS one
Published: February 27, 2017

Cilengitide and Cetuximab Reduce Cytokine Production and Colony Formation of Head and Neck Squamous Cell Carcinoma Cells Ex Vivo.

Cilengitide and Cetuximab Reduce Cytokine Production and Colony Formation of Head and Neck Squamous Cell Carcinoma Cells Ex Vivo.

Journal: Anticancer research
Published: November 23, 2016
Showing 1-12 of 16

Last Updated: 09/26/2026